Strey C. H., Young, J. M., Molyneux, S. L. et al. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. Atherosclerosis, 179: Issue 1, 201–206, 2005.
Swedberg, K. Beta blockers in heart failure. How it all began. J. Am. Coll. Cardiol., ACC Curr. J. Rev. January/February, 61, 2001.
Valgimigli, M., Ceconi, C, Malagutti, P. et al. Tumor necrosis factor-a receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation, 111:863–870, 2005.
Weinstein, A. R., Sesso, H. D., Lee, I. M. et al. Relationship of physical activity versus body mass index with type II diabetes in women. JAMA, 292:1188–1194, 2004.
Wiksrrand, J., Hjallmarson, A., Waagstein, F. et al. Dose of metoprolol CR/ZL and clinical outcomes in patients with heart failure. J. Am. Coll. Cardiol., 40:491, 2002.
Young, J. B., William, T., Abraham, M. D., Smith, A. L. et al for The Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators Combined Cardiac Resynchro-nization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure. The MIRACLE ICD Trial. JAMA, 289:2685–2694, 2003.

Страницы: 1 | 2 | 3 | 4 | 5 | 6